language-icon Old Web
English
Sign In
Acemap > Paper > Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease

2017 
Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    93
    References
    21
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.